Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.7127 per EA under NDC 31722063031. Its NADAC has been published 420 times since Jun 13, 2018.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722063031
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA209438On Market Since
2/23/2018
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 420 times since Jun 13, 2018, and over the history we have for it it has declined 90.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7127 per EA |
|---|---|
| All-time high | $8.1216 (Oct 10, 2018) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $1.5913 |
| Average price | $2.6024 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 420 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.7127 per EA (NDC 31722063031), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 90.3%. It has been tracked across 420 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Jun 13, 2018, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.1216 (Oct 10, 2018), with a median of $1.5913 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 30 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 31722063031) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification